Competing for Great Britain in the 2026 Paralympics, Nina Sparks is taking her snowboard to Italy and is hoping to stand on the podium at the Paralympic Winter Games. She was diagnosed with MS in 2020 ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.

This useful study supplements previous publications of willed attention by addressing a frontoparietal network that supports internal goal generation. The evidence is solid in analyzing two datasets ...

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

For nearly 15 years, Ruth Bollo knew something was wrong.Her vision would suddenly jump from side to side. She suffered vertigo, severe headaches, and balance problems that made everyday life ...

Everclear frontman Art Alexakis opens up about living with living with multiple sclerosis for more than a decade, the early signs he missed, and why he considers his diagnosis a "blessing.' ...

For nearly 15 years, Ruth Bollo knew something was wrong. Her vision would suddenly jump from side to side. She suffered vertigo, severe headaches, and balance problems that made everyday life ...

Pat McAfee has answered recent criticism with a high-profile act of generosity, making a $50,000 donation to support Fernando Mendoza's campaign benefiting the National MS Society.

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...

Paramagnetic rim lesions may help assess MS risk in people with radiologically isolated syndrome before symptoms appear.